Repeated Non-invasive Fibrosis Tests to Monitor NAFLD Repeated Non-invasive Fibrosis Tests to Monitor NAFLD
Are blood-based non-invasive tests for fibrosis monitoring at 2-3-year intervals sufficient for determining progression of NAFLD?Liver International (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 16, 2022 Category: Pathology Tags: Gastroenterology Journal Article Source Type: news

Fatty liver disease: The vitamin that could potentially treat advanced form of condition
WHILE the early stages of non-alcoholic fatty liver disease aren't usually harmful, the advanced form of this condition can stir up some "serious" problems. However, researchers believe they might have identified a vitamin that could potentially treat a later stage of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - August 7, 2022 Category: Consumer Health News Source Type: news

NAFLD Linked With Increased Heart Failure Risk NAFLD Linked With Increased Heart Failure Risk
The risk appears to increase with greater liver disease severity, especially at higher fibrosis stages.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 4, 2022 Category: Cardiology Tags: Gastroenterology News Source Type: news

Clinical Prediction Rules for Ruling Out Cirrhosis in NAFLD Clinical Prediction Rules for Ruling Out Cirrhosis in NAFLD
This study shows that the use of new cutoffs for FIB-4 or the NAFLD Fibrosis Score can accurately rule out cirrhosis in patients with NAFLD.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Updated Meta-Analysis Links NAFLD to Increased Risk for Heart Failure
TUESDAY, July 26, 2022 -- Nonalcoholic fatty liver disease (NAFLD) is associated with an increased long-term risk for new-onset heart failure, according to research published online July 25 in Gut. Alessandro Mantovani, M.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 26, 2022 Category: Pharmaceuticals Source Type: news

New Guidelines Focus on NAFLD in Lean People New Guidelines Focus on NAFLD in Lean People
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts who underline the risk for comorbid conditions and cirrhosis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 26, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news

New Update Focuses on NAFLD in Lean People New Update Focuses on NAFLD in Lean People
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts who underline the risk for comorbid conditions and cirrhosis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 26, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Fat Around the Liver Raises Risk for Heart Failure
TUESDAY, July 26, 2022 -- About 30% of adults around the world have a buildup of fat in the liver, a condition called nonalcoholic fatty liver disease. Now an international team of researchers has linked that condition to a heightened risk of heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 26, 2022 Category: General Medicine Source Type: news

NAFLD Tied to Higher Risk of Heart Failure
(MedPage Today) -- Middle-age patients with non-alcoholic fatty liver disease (NAFLD) had a moderately higher risk of developing heart failure, an updated meta-analysis found. Pooled data on over 11 million participants showed NAFLD to be associated... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 26, 2022 Category: Cardiology Source Type: news

NAFLD Strongly Correlated With Psoriasis, PsA NAFLD Strongly Correlated With Psoriasis, PsA
The 11 observational studies included in the meta-analysis met stringent criteria, including a diagnosis of psoriasis and PsA based on objective criteria, and NAFLD confirmed with liver biopsy or imaging.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 22, 2022 Category: Consumer Health News Tags: Dermatology News Source Type: news

The Paradigm Shift From NAFLD to MAFLD The Paradigm Shift From NAFLD to MAFLD
In this paper, the authors provide perspective regarding the redefinition of NAFLD to MAFLD and how it will improve the implementation of effective fatty liver disease management in primary care.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Liver Disease a New Dementia Risk Factor? Liver Disease a New Dementia Risk Factor?
Patients with nonalcoholic fatty liver disease are at risk for developing dementia -- and NAFLD plus cardiovascular disease or stroke hikes the risk even more, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 14, 2022 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

NAFLD Linked to Increased Risk for Dementia in Seniors
THURSDAY, July 14, 2022 -- Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk for dementia among older adults, according to a study published online July 13 in Neurology. Ying Shang, Ph.D., from the Karolinska Institutet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2022 Category: Pharmaceuticals Source Type: news

NAFLD Tied to Higher Dementia Risk
(MedPage Today) -- Non-alcoholic fatty liver disease (NAFLD) was associated with an increased rate of dementia in older adults, a population-based Swedish cohort study showed. In an analysis of 31,255 people 65 and older, those with NAFLD had... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - July 13, 2022 Category: Psychiatry Source Type: news

113-Gene Signature May Predict Long-Term HCC Risk in NAFLD
TUESDAY, July 12, 2022 -- A 113-gene signature may predict long-term risk for incident hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease (NAFLD), according to a study published online June 22 in Science Translational... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 12, 2022 Category: Pharmaceuticals Source Type: news